Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) closed the day trading at $8.08 down -1.10% from the previous closing price of $8.17. In other words, the price has decreased by -$1.10 from its previous closing price. On the day, 2.53 million shares were traded. AVAH stock price reached its highest trading level at $8.2594 during the session, while it also had its lowest trading level at $7.68.
Ratios:
For a better understanding of AVAH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.00. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 164.49 whereas as Long-Term Debt/Eq ratio is at 143.34.
On November 13, 2025, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $11.
JP Morgan Upgraded its Underweight to Neutral on September 18, 2025, while the target price for the stock was maintained at $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 30 ’25 when Cunningham Patrick A. sold 11,839 shares for $8.36 per share. The transaction valued at 98,922 led to the insider holds 317,530 shares of the business.
Cunningham Patrick A. sold 12,445 shares of AVAH for $97,634 on Jan 02 ’26. The Chief Compliance Officer now owns 293,354 shares after completing the transaction at $7.85 per share. On Dec 31 ’25, another insider, Cunningham Patrick A., who serves as the Chief Compliance Officer of the company, sold 11,731 shares for $8.18 each. As a result, the insider received 95,933 and left with 305,799 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 1688003840 and an Enterprise Value of 3045594880. As of this moment, Aveanna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.44, and their Forward P/E ratio for the next fiscal year is 13.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.74 while its Price-to-Book (P/B) ratio in mrq is 183.80. Its current Enterprise Value per Revenue stands at 1.33 whereas that against EBITDA is 11.432.
Stock Price History:
The Beta on a monthly basis for AVAH is 2.06, which has changed by 0.79157424 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $10.32, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is -9.85%, while the 200-Day Moving Average is calculated to be 19.26%.
Shares Statistics:
Over the past 3-months, AVAH traded about 1.36M shares per day on average, while over the past 10 days, AVAH traded about 1388630 shares per day. A total of 208.91M shares are outstanding, with a floating share count of 68.97M. Insiders hold about 66.99% of the company’s shares, while institutions hold 25.67% stake in the company. Shares short for AVAH as of 1765756800 were 3619836 with a Short Ratio of 2.67, compared to 1763078400 on 4452357. Therefore, it implies a Short% of Shares Outstanding of 3619836 and a Short% of Float of 5.2800003.
Earnings Estimates
Current recommendations for the stock of the company come from 11.0 analysts. The consensus estimate for the next quarter is $0.13, with high estimates of $0.15 and low estimates of $0.1.
Analysts are recommending an EPS of between $0.59 and $0.46 for the fiscal current year, implying an average EPS of $0.55. EPS for the following year is $0.59, with 11.0 analysts recommending between $0.72 and $0.37.
Revenue Estimates
10 analysts predict $621.53M in revenue for. The current quarter. It ranges from a high estimate of $644.35M to a low estimate of $609M. As of. The current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $519.87MFor the next quarter, 10 analysts are estimating revenue of $619.51M. There is a high estimate of $635.8M for the next quarter, whereas the lowest estimate is $589.9M.
A total of 10 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $2.42B, while the lowest revenue estimate was $2.38B, resulting in an average revenue estimate of $2.39B. In the same quarter a year ago, actual revenue was $2.02BBased on 10 analysts’ estimates, the company’s revenue will be $2.57B in the next fiscal year. The high estimate is $2.59B and the low estimate is $2.52B.
